These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6395351)

  • 1. The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria.
    Ittiravivongs A; Vasuvat C; Kongrod S
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):323-5. PubMed ID: 6395351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
    Kupferschmidt HG; Schröder K; Beltzner B
    Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria in the province of Takeo, Cambodia.
    Giboda M
    Folia Parasitol (Praha); 1985; 32(3):205-10. PubMed ID: 3899874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falciparum malaria resistant to Fansidar (sulphadoxine-pyrimethamine) occurring in three children of the same family.
    Ponnampalam JT
    Singapore Med J; 1982 Feb; 23(1):37-8. PubMed ID: 7051329
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
    Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Kanjanapipatkul K; Doberstyn EB; Suebsaeng L
    Bull World Health Organ; 1985; 63(3):597-602. PubMed ID: 3899396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
    Chongsuphajaisiddhi T; Youngchaiyudha S; Rungpitarangsri V; Trishnananda M; Ruksakul T; Charnond L; Boonamrung S
    Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):524-7. PubMed ID: 7013094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
    Hurwitz ES; Johnson D; Campbell CC
    Lancet; 1981 May; 1(8229):1068-70. PubMed ID: 6112445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
    Burchard GD; Winkler E
    Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
    Al-Yaman F; Genton B; Mokela D; Alpers MP
    P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of area under the curve to characterize transmission potential after antimalarial treatment.
    Méndez F; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2006 Oct; 75(4):640-4. PubMed ID: 17038686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
    Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
    Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Darlow B; Vrbova H; Stace J; Heywood P; Aalpers M
    Lancet; 1980 Dec; 2(8206):1243. PubMed ID: 6108409
    [No Abstract]   [Full Text] [Related]  

  • 18. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fansidar prophylaxis, therapy, and immune responses in rodent malaria (Plasmodium berghei).
    Ferraroni JJ; Speer CA
    J Parasitol; 1982 Aug; 68(4):609-15. PubMed ID: 6750070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.